WellDoc BlueStar vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by WellDoc
VS
by RIVERAIN TECHNOLOGIES

AI Verdict

WellDoc BlueStar is designed for patient-facing chronic disease management, offering personalized coaching and data tracking for conditions like diabetes and heart failure. In contrast, ClearRead CT is a diagnostic tool for radiologists, utilizing AI to enhance the detection of pulmonary nodules and coronary artery calcification in CT scans. While both operate within the cardiology domain, WellDoc focuses on patient engagement and self-management, whereas ClearRead CT aids in diagnostic imaging interpretation.

Choose WellDoc BlueStar if…

Choose WellDoc BlueStar if your organization aims to empower patients with chronic conditions like diabetes, hypertension, or heart failure through personalized, AI-driven coaching and remote monitoring. This tool is ideal for improving patient self-management, adherence to treatment plans, and overall health outcomes by integrating data from various connected devices and providing real-time feedback.

View WellDoc BlueStar →

Choose ClearRead CT if…

Choose ClearRead CT if your radiology department or healthcare system seeks to enhance the accuracy and efficiency of cardiothoracic CT scan interpretations. This solution is best suited for improving the detection of pulmonary nodules and automating coronary artery calcification scoring, thereby streamlining radiologist workflows and reducing diagnostic errors.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature WellDoc BlueStar ClearRead CT
Pricing Enterprise pricing; paid by health plans, health systems, or employers. Contact for pricing
Deployment Mobile app (iOS, Android) and web-based platform On-premise (stand-alone server, virtual machine) and Cloud
FDA Status 1 AI-estimated 1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature WellDoc BlueStar ClearRead CT
Primary Use Case AI-powered digital health solution for chronic disease management, offering personalized coaching and insights for conditions like diabetes, hypertension, and heart failure. FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
Company WellDoc RIVERAIN TECHNOLOGIES
Target Specialties Cardiology, Endocrinology, Internal Medicine Cardiology, Pulmonology, Radiology
Key AI-driven Capabilities AI-driven personalized coaching, multi-condition support (diabetes, hypertension, heart failure, weight management, behavioral health), insulin dose recommendations, real-time feedback and educational content, care team portal for providers, SMARTVisit reports. Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression, Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring.

Videos

Demos, reviews, and walkthroughs featuring WellDoc BlueStar and ClearRead CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

WellDoc BlueStar integrates by providing AI-driven personalized coaching directly to patients for chronic disease management, with a care team portal and SMARTVisit reports for physician review in specialties like Cardiology, Endocrinology, and Internal Medicine. ClearRead CT integrates seamlessly into radiology PACS workflows, assisting radiologists, pulmonologists, and cardiologists with enhanced pulmonary nodule detection and coronary artery calcification analysis to improve diagnostic accuracy and reduce reading times.
WellDoc BlueStar generates SMARTVisit reports for healthcare providers and offers data logging capabilities for various health metrics, allowing providers to review patient progress and insights that can be incorporated into EHRs. ClearRead CT focuses on seamless PACS integration, enhancing diagnostic imaging workflows, where its analytical findings would typically be documented by the radiologist's reporting system into the patient's EHR.
ClearRead CT has demonstrated improved detection accuracy with a 29% reduction in missed actionable nodules and reduced reading times by up to 36% in cardiothoracic CT scans. WellDoc BlueStar is an FDA-cleared digital health solution offering AI-driven personalized coaching and insulin dose recommendations for chronic conditions like diabetes, hypertension, and heart failure, indicating clinical validation for its features and intended use.
WellDoc BlueStar, being a mobile app and web-based platform for patient engagement and provider review, likely has a relatively low learning curve for both patients and care teams to access and interpret reports. ClearRead CT, integrated into PACS, requires radiologists to learn to interpret its AI-enhanced imaging and incorporate its findings into their diagnostic workflow, potentially requiring some initial training to optimize its use.
WellDoc BlueStar provides data logging capabilities for various health metrics (glucose, BP, weight, sleep, meals, exercise) and generates SMARTVisit reports for providers, which can serve as a record of patient progress and AI-driven insights. ClearRead CT offers automated nodule tracking and comparison to prior exams, creating a clear record of AI-assisted diagnostic findings and changes over time for accountability and longitudinal patient care.
ClearRead CT can offer more immediate operational value through reduced reading times and improved detection accuracy per scan, directly impacting daily radiology workflow efficiency and diagnostic confidence. WellDoc BlueStar's value accrues over time through sustained patient engagement in chronic disease management, leading to improved long-term health outcomes, better disease control, and potentially reduced healthcare utilization.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.